CD34+ Enriched Transplant
A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Myelodysplastic Syndrome
More Information
- Trial Status
- Not currently accepting
- Trial Phase
- Phase 2
- Enrollment
- 50 patients (estimated)
- Tags
- Allogeneic Stem Cell Transplant, T Cell, CD34
- Trial Type
- Treatment
- Last Update
- 3 weeks ago
- SparkCures ID
- 1497
- NCT Identifier
- NCT05617625
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.